CNR1 and Parkinson disease: As a partial agonist of CB1 and CB2 receptors, THC regulates the activity of this system, which presents abnormal levels of endocannabinoids, contributing to the regulation of neuroinflammatory and neuroprotective processes that are essential in managing PD (More and Choi, 2015).